Home > Quotes > ALIM

Alimera Sciences, Inc. Common Stock Quote & Summary Data

ALIM 
$2.36
*  
unch
unch
Get ALIM Alerts
*Delayed - data as of Apr. 28, 2016  -  Find a broker to begin trading ALIM now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    ALIM After Hours
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Alimera Sciences, Inc. Common Stock Intraday Chart




News for ALIM

Shares Traded

Trading Range

Intraday Last 52 Weeks
High $ 2.58 $ 5.15
Low $ 2.33 $ 1.49

The current last sale of $2.36 is 58.39% Higher thanthe 52 week low.

P/E Ratio

Company Description (as filed with the SEC)

Alimera Sciences, Inc., and its subsidiaries (we, Alimera or the Company), is a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals. We are presently focused on diseases affecting the back of the eye, or retina, because we believe these diseases are not well treated with current therapies and represent a significant market opportunity. Our only commercial product is ILUVIENĀ®, which has been developed to treat diabetic macular edema (DME). DME is a disease of the retina that affects individuals with diabetes and can lead to severe vision loss and blindness. ILUVIEN has received marketing authorization in the U.S., Austria, Belgium, the Czech Republic, Denmark, Finland, France, Germany, Ireland, Italy, Luxembourg, the Netherlands, Norway, Poland, Portugal, Spain, Sweden and the United Kingdom.  ... More ...  

Risk Grade

Where does ALIM fit in the risk graph?


Risk Grade Scale

Nasdaq Official Price

Consensus Recommendation

Research Brokers before you trade

Want to trade FX?